ARTHROCARE, Texas (ap) - medical products manufacturer, said on Tuesday that it has completed about 45 million dollars in cash for ENTrigue surgery company.
Purchase price, including potential milestone payment, if you meet certain sales growth targets, in the next five years, the company said.
ENTrigue design and development of the implants, consumables and instruments endoscopic sinus surgery. It will operate otolaryngology ARTHROCARE products field, ARTHROCARE said.
Headquartered in Austin, Texas, shares ARTHROCARE fell 9 cents, to $34.79 in morning trading. They have a 52-week range $27.21 at $36.99, buy and sell.



Other News:
ArthroCare completes $45M deal for ENTrigue
Pa. McDonald's franchise to offer more pay options
Federal drug bust nets 22 suspects in ND oil patch
Egypt's military gives Morsi 48-hour ultimatum
Ahead of the Bell: DaVita HealthCare shares slide
Vatican monsignor questioned in corruption plot.
US home prices rise in May by most in 7 years
Shares, oil bounce higher despite Fed concerns